Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02471586 · ClinicalTrials.gov registry record · NA

OPTIMIZE PCI: Multicenter Randomized Trial of OCT Compared to IVUS and Angiography to Guide Coronary Stent Implantation

A NA study of Coronary Artery Disease, sponsored by Abbott Medical Devices.

Completed
Registry status
NA
Development phase
450
Enrollment target
20
Study locations

NCT02471586 is a NA study of Coronary Artery Disease that has completed, run by Abbott Medical Devices. The registered enrollment target is 450 participants, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (65% lower). The trial reports 20 study locations across 16 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02471586, a NA study of Coronary Artery Disease, has completed, sponsored by Abbott Medical Devices.

COMPLETED
Registry status
NA
Development phase
450 participants
Enrollment target
20
Study locations

Study Summary

The objective of this clinical investigation is to demonstrate the safety and efficacy of an OCT guided strategy for stent implantation

Conditions Studied

Coronary Artery Disease

Interventions

  • PROCEDURE Coronary PCI guided by IVUS
  • PROCEDURE Coronary PCI guided by OCT
  • PROCEDURE Coronary PCI guided by Angiography

Study Locations (20)

New York

  • New York Presbyterian Hospital/Columbia University - New York
  • Lenox Hill Hospital - New York
  • St. Francis Hospital - Roslyn

Texas

  • Austin Heart - Austin
  • Memorial Hermann Hospital - Houston
  • The University of Texas Health Science at San Antonio - San Antonio

Alabama

  • University Hospital - Univ. of Alabama at Birmingham (UAB) - Birmingham

Arizona

  • Scottsdale Healthcare Shea - Scottsdale

California

  • University of California at San Diego (UCSD) Medical Center - San Diego

Colorado

  • Heart Institute of Colorado - Broomfield

Florida

  • Orlando Health - Orlando

Georgia

  • Emory University Hospital - Atlanta

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2015-05
Est. Completion 2017-04-25
Phase NA

Sponsor

Abbott Medical Devices

261 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02471586

The ClinicalTrials.gov registry entry for NCT02471586 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (65% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 3 interventions - of which Coronary PCI guided by IVUS is the first listed.

NCT02471586 reports 20 study locations spanning 16 distinct geographic areas - top geographies include New York, Texas, Alabama.

Frequently Asked Questions

What is clinical trial NCT02471586 about?

NCT02471586 is a clinical study titled "OPTIMIZE PCI: Multicenter Randomized Trial of OCT Compared to IVUS and Angiography to Guide Coronary Stent Implantation". The objective of this clinical investigation is to demonstrate the safety and efficacy of an OCT guided strategy for stent implantation

What is the current status of trial NCT02471586?

This trial is currently completed. It is a NA study. The enrollment target is 450 participants. The study started on 2015-05. Estimated completion is 2017-04-25.

What conditions does trial NCT02471586 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT02471586?

The interventions under investigation include: Coronary PCI guided by IVUS (PROCEDURE), Coronary PCI guided by OCT (PROCEDURE), Coronary PCI guided by Angiography (PROCEDURE).

Who is sponsoring clinical trial NCT02471586?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02471586 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Coronary Artery Disease

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.